Navigation path

  • Print version
  • Decrease text
  • Increase text

Drug control policy - Newsroom

Green Paper

Date: 30/09/2006

When developing policy and legislation, the European Commission consults widely with EU citizens and stakeholders through public consultations.

Green Paper

The public consultation Green Paper on the role of Civil Society in Drugs Policy in the European Union български (bg)czech (cs)dansk (da)Deutsch (de)eesti (et)ελληνικά (el)español (es)Français (fr)Gaeilge (ga)italiano (it)latviešu (lv)lietuvių (lt)magyar (hu)Malti (mt)Nederlands (nl)polski (pl)português (pt)română (ro)slovenčina (sk)slovenščina (sl)suomi (fi)svenska (sv) was launched in 2006 to bring those most directly concerned by the drugs problem more closely into the EU policy-making process and to:

  • improve the policy outcome and involvement of stakeholders;
  • make the EU less of a "distant entity" by simplifying communication with policy makers;
  • reflect the fact that civil society often bears considerable responsibility for action at local level and achieving the objectives of drug prevention, treatment and rehabilitation of drug users;
  • recognise the value of innovative approaches developed by NGOs and voluntary groups, based on a realistic picture of what is actually needed.

Civil society organisations are most typically involved in reducing drug demand, but their role in reducing supply should not be underestimated (e.g. helping to tackle local drug markets). Many organisations also have experience of working in the drugs field in other countries through development work.

See contributions

Drug control policy - Public consultations

Other topics - Public consultations